Abstract
We have used chicken cDNA microarrays to investigate gene-expression changes induced during transformation of chick embryo fibroblasts (CEF) by the viral Jun oncoprotein encoded by ASV17. This analysis reveals that v-Jun induces increases and decreases of varying magnitude in the expression of genes involved in diverse cellular functions, most of which have not been detected in previous screens for putative v-Jun targets. In all, 27 individual genes were identified, whose expression is increased threefold or more in v-Jun-transformed cells, including genes involved in energy generation, protein synthesis, and gene transcription. Interestingly, this group includes the hypoxia-inducible factor-1 alpha (Hif-1α) transcription factor and the glycolytic enzyme enolase, suggesting that adaptation to hypoxia could play a role in tumorigenesis by v-Jun. We also identified 32 genes whose expression is decreased threefold or more, including chaperones, components of the cytoskeleton, and, unexpectedly, DNA replication factors. The gene whose expression is upregulated most dramatically (∼100-fold) encodes Autotaxin (ATX), a secreted tumor motility-promoting factor with lysophospholipase D activity. Strikingly, v-Jun-transformed CEF secrete catalytically active ATX and chemotactic activity, which can be detected in conditioned medium. ATX is not detectably expressed in normal CEF or CEF transformed by the v-Src or v-Myc oncoproteins, indicating that induction of this putative autocrine/paracrine factor is a specific consequence of cell transformation by v-Jun. ATX has been implicated in both angiogenesis and invasion, and could therefore play an important role in tumorigenesis by v-Jun in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alfranca A, Gutierrez MD, Vara A, Aragones J, Vidal F and Landazuri MO . (2002). Mol. Cell. Biol., 22, 12–22.
Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P and Karin M . (1987). Cell, 49, 729–739.
Bader AG, Schneider ML, Bister K and Hartl M . (2001). Oncogene, 20, 7524–7535.
Bates S, Rowan S and Vousden KH . (1996). Oncogene, 13, 1103–1109.
Beere HM . (2001). Sci. STKE, 2001, RE1.
Bollen M, Gijsbers R, Ceulemans H, Stalmans W and Stefan C . (2000). Crit. Rev. Biochem. Mol. Biol., 35, 393–432.
Bos TJ, Monteclaro FS, Mitsunobu F, Ball Jr AR, Chang CH, Nishimura T and Vogt PK . (1990). Genes Dev., 4, 1677–1687.
Cavalieri F, Ruscio T, Tinoco R, Benedict S, Davis C and Vogt PK . (1985). Virology, 143, 680–683.
Chen F, Castranova V and Shi X . (2001). Am. J. Pathol., 159, 387–397.
Chinenov Y and Kerppola TK . (2001). Oncogene, 20, 2438–2452.
Clair T, Lee HY, Liotta LA and Stracke ML . (1997). J. Biol. Chem., 272, 996–1001.
Clark W, Black EJ, MacLaren A, Kruse U, LaThangue N, Vogt PK and Gillespie DA . (2000). Mol. Cell. Biol., 20, 2529–2542.
Clark W and Gillespie DA . (1997). Cell Growth Differ., 8, 371–380.
Cohen SB, Waha A, Gelman IH and Vogt PK . (2001). Oncogene, 20, 141–146.
Dang CV and Semenza GL . (1999). Trends Biochem. Sci., 24, 68–72.
Dunn CA, Clark W, Black EJ and Gillespie DA . (2003). Biochim. Biophys. Acta, 1628, 147–155.
Fu S, Bottoli I, Goller M and Vogt PK . (1999). Proc. Natl. Acad. Sci. USA, 96, 5716–5721.
Gao M, Morgan I and Vogt PK . (1996). Cancer Res., 56, 4229–4235.
Hadman M, Gabos L, Loo M, Sehgal A and Bos TJ . (1996). Oncogene, 12, 135–142.
Harris AL . (2002). Nat. Rev. Cancer, 2, 38–47.
Hartl M, Reiter F, Bader AG, Castellazzi M and Bister K . (2001). Proc. Natl. Acad. Sci. USA, 98, 13601–13606.
Havarstein LS, Morgan IM, Wong WY and Vogt PK . (1992). Proc. Natl. Acad. Sci. USA, 89, 618–622.
Hughes SH, Greenhouse JJ, Petropoulos CJ and Sutrave P . (1987). J. Virol., 61, 3004–3012.
Inohara N, Ekhterae D, Garcia I, Carrio R, Merino J, Merry A, Chen S and Nunez G . (1998). J. Biol. Chem., 273, 8705–8710.
Jones SE and Jomary C . (2002). Int. J. Biochem. Cell Biol., 34, 427–431.
Kilbey A, Black EJ, Unlu M and Gillespie DA . (1996). Oncogene, 12, 2409–2418.
Koh E, Clair T, Woodhouse EC, Schiffmann E, Liotta L and Stracke M . (2003). Cancer Res., 63, 2042–2045.
Kruse U, Iacovoni JS, Goller ME and Vogt PK . (1997). Proc. Natl. Acad. Sci. USA, 94, 12396–12400.
Lamb RF, Hennigan RF, Turnbull K, Katsanakis KD, MacKenzie ED, Birnie GD and Ozanne BW . (1997). Mol. Cell. Biol., 17, 963–976.
Lee HY, Bae GU, Jung ID, Lee JS, Kim YK, Noh SH, Stracke ML, Park CG, Lee HW and Han JW . (2002). FEBS Lett., 515, 137–140.
Maki Y, Bos TJ, Davis C, Starbuck M and Vogt PK . (1987). Proc. Natl. Acad. Sci. USA, 84, 2848–2852.
Moolenaar WH . (2002). J. Cell Biol., 158, 197–199.
Morgan IM, Asano M, Havarstein LS, Ishikawa H, Hiiragi T, Ito Y and Vogt PK . (1993). Oncogene, 8, 1135–1140.
Nam SW, Clair T, Campo CK, Lee HY, Liotta LA and Stracke ML . (2000). Oncogene, 19, 241–247.
Nam SW, Clair T, Kim YS, McMarlin A, Schiffmann E, Liotta LA and Stracke ML . (2001). Cancer Res., 61, 6938–6944.
Neiman PE, Ruddell A, Jasoni C, Loring G, Thomas SJ, Brandvold KA, Lee R, Burnside J and Delrow J . (2001). Proc. Natl. Acad. Sci. USA, 98, 6378–6383.
Nishimura T and Vogt PK . (1988). Oncogene, 3, 659–663.
Salnikow K, Kluz T, Costa M, Piquemal D, Demidenko ZN, Xie K and Blagosklonny MV . (2002). Mol. Cell. Biol., 22, 1734–1741.
Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, Karin M, Angel P and Wagner EF . (1999). Genes Dev., 13, 607–619.
Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P and Giallongo A . (1996). J. Biol. Chem., 271, 32529–32537.
Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E and Liotta LA . (1992). J. Biol. Chem., 267, 2524–2529.
Treier M, Staszewski LM and Bohmann D . (1994). Cell, 78, 787–798.
Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Takio K, Yamori T, Mills GB, Inoue K, Aoki J and Arai H . (2002). J. Cell Biol., 158, 227–233.
Vial E, Perez S and Castellazzi M . (2000). Oncogene, 19, 5020–5029.
Vogt PK . (2001). Oncogene, 20, 2365–2377.
Wong WY, Havarstein LS, Morgan IM and Vogt PK . (1992). Oncogene, 7, 2077–2080.
Acknowledgements
We are grateful to Dr K Vass and A Kotwaliwale for help with initial computer analysis of the microarray data, and to Professor JA Wyke, Dr K Ryan, and Professor B Ozanne for comments on the manuscript. This work was supported by Cancer Research UK (formerly Cancer Research Campaign of the UK) and also by National Cancer Institute Grant RO1 CA20068 (to PN).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Black, E., Clair, T., Delrow, J. et al. Microarray analysis identifies Autotaxin, a tumour cell motility and angiogenic factor with lysophospholipase D activity, as a specific target of cell transformation by v-Jun. Oncogene 23, 2357–2366 (2004). https://doi.org/10.1038/sj.onc.1207377
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1207377
Keywords
This article is cited by
-
Loss of FOXF1 expression promotes human lung-resident mesenchymal stromal cell migration via ATX/LPA/LPA1 signaling axis
Scientific Reports (2020)
-
Cholera toxin inhibits human hepatocarcinoma cell proliferation in vitro via suppressing ATX/LPA axis
Acta Pharmacologica Sinica (2011)
-
Autotaxin and LPA receptor signaling in cancer
Cancer and Metastasis Reviews (2011)
-
Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression
British Journal of Cancer (2010)
-
Autotaxin
Cellular and Molecular Life Sciences (2009)